SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported)             September 19, 2001            

PHARMACIA CORPORATION (Exact Name of Registrant as Specified in Its Charter)

Delaware	1- 2516	43-0420020
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

100 Route 206 North, Peapack, New Jersey	07977
(Address of Principal Executive Offices)	(Zip Code)

(908) 901-8000 (Registrant’s Telephone Number, Including Area Code)


N/A (Former Name or Former Address, if Changed Since Last Report)

Item 5.     Other Events.

                On September 19, 2001, the Registrant announced that its Board of Directors has authorized a stock repurchase program of up to $1 billion over the next two years.

                A copy of the press release issued by the Registrant on September 19, 2001 is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 7.     Financial Statements, Pro Forma Financial Information and Exhibits.

(c)	Exhibits. The following exhibit is filed as part of this Current Report on Form 8-K:
	99.1	Press Release of September 19, 2001.

SIGNATURES

             Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	PHARMACIA CORPORATION
Dated: September 20, 2001	By:	/s/ Don W. Schmitz
		Name: Title:	Don W. Schmitz Vice President, Associate General Counsel and Corporate Secretary

INDEX TO EXHIBITS

Exhibit No.	Exhibit
99.1	Press Release of September 19, 2001.